Skip to main content

Genetic Evidence Supports Causal Effect for Diastolic BP on Benign Prostatic Hyperplasia

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Aug. 3, 2023 -- There is genetic evidence supporting a causal effect of diastolic blood pressure (DBP) on benign prostatic hyperplasia (BPH), according to a study published online July 16 in The Prostate.

Kaikai Lv, M.D., from The Chinese People's Liberation Army General Hospital in Beijing, and colleagues conducted a two-sample Mendelian randomization (MR) study to examine the causality of metabolic syndrome (MetS) and its components on BPH using summary-level data from genome-wide association studies. Data were included for 26,358 BPH cases and 110,070 controls.

The researchers observed significant positive associations for genetically predicted waist circumference and DBP with BPH risk. No causal effect was seen for MetS, systolic blood pressure, triglycerides, high-density lipoprotein, or fasting blood glucose on BPH. The risk effect of DBP on BPH persisted after conditioning with waist circumference in the multivariable MR analysis, but no significant association for waist circumference was observed.

"Our MR study provides genetic evidence supporting the causal effect of DBP on BPH. However, the role of increased waist circumference in the risk of developing BPH requires further validation," the authors write. "Our results suggest that the management of DBP may prevent BPH development."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Echocardiogram Can ID Women With Preeclampsia at Risk for Future HTN

WEDNESDAY, June 26, 2024 -- Echocardiography during pregnancy or early postpartum can assist in identifying women with preeclampsia at greater risk of future hypertension...

Vigorous Physical Activity May Preserve Cognitive Function in High-Risk HTN

MONDAY, June 24, 2024 -- For high-risk patients with hypertension, vigorous physical activity (VPA) may preserve cognitive function, according to a study published online June 6...

Angiotensin Receptor Blocker Use Linked to Lower Incidence of Epilepsy

FRIDAY, June 21, 2024 -- For patients with hypertension, angiotensin receptor blockers (ARBs) are associated with a reduced incidence of epilepsy compared with other...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.